Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

Michael Friis

Head of Equities

Michael Friis portrait

Coverage

HydractAudientesRealfictionShape RoboticsScape TechnologiesGreenMobilityCurasightOrderYOYOPenneoPhotocatOdicoAgillicBawat Water TechnologiesImperoMapsPeopleNNITNordic SolarScandinavian Medical SolutionsWindowMaster InternationalGomSpace GroupCABA CapitalAscelia PharmaEmbla MedicalBioPortoGubraExpreS2ion Biotech Holding

Latest content

ShowingAll content types

GreenMobility: Recording of preliminary 2025 results and 2026 guidance presentation

Analyst Comment 30.01.2026 klo 09.08 by Michael Friis
GreenMobility

Columbus: Growth challenged, but sequential margin improvement

Analyst Comment 27.01.2026 klo 15.18 by Michael Friis
Columbus

GomSpace (One-pager): 2026 guidance - another year of high topline growth expected

Research 20.01.2026 klo 14.20 by Michael Friis, Victor Skriver
GomSpace Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account

GomSpace – Strategic direction & Q&A (Recording)

Analyst Comment 20.01.2026 klo 10.13 by Michael Friis
GomSpace Group

GreenMobility: 2026 outlook aligns with Strategy 2028 ambitions

Analyst Comment 19.01.2026 klo 11.45 by Michael Friis
GreenMobility

WindowMaster: Strategic partnership supports project flow and earnings scalability

Analyst Comment 15.01.2026 klo 16.39 by Michael Friis
WindowMaster International

Curasight (One-pager): Entering Clinical Validation of a uPAR Theranostic Platform

Research 22.12.2025 klo 13.36 by Philip Coombes, Michael Friis
Curasight

GreenMobility: expects to activate DKK 15 million in deferred tax assets in 2025

Analyst Comment 19.12.2025 klo 09.15 by Michael Friis
GreenMobility

WindowMaster: 2026 guidance points to back on track

Research 17.12.2025 klo 16.00 by Michael Friis, Philip Coombes
WindowMaster International

WindowMaster: Strong 2026 guidance signals step-change in profitability and growth

Analyst Comment 16.12.2025 klo 16.24 by Michael Friis
WindowMaster International
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.